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The α1-acid glycoprotein (AAG) is a prototypical se-
rum acute phase reactant in most mammalian species; 
it is synthesized mainly in liver parenchymal cells. Re-
cently, we found that mRNAs of AAG were expressed 
in non-hepatic cancer cells, and the expression levels 
were regulated by the cytokines - IL-1, IL-6, and TNF-
α. The functional role of AAG in non-hepatic cancer 
cells has not yet been established. In order to under-
stand the functional role of the AAG expressed in HT-
29 cells, the cancer cells were transfected with cloned 
cDNA for AAG, or exposed to antisense 
oligodeoxynucleotide (ODN) for AAG. The colony-
forming capacity, invasion, and adhesion to laminin of 
these transformed cancer cells were measured. Over-
expression of AAG by transfection, and inhibition of 
the AAG expression by antisense ODNs were identified 
by Western blot as well as nested reverse transcrip-
tase-polymerase chain reaction (nested RT-PCR), re-
spectively. Results showed that the overexpression of 
AAG by transfection reduced colony-forming capaci-
ties, invasion, and adhesion to laminin of the cancer 
cells; on the other hand, the antisense ODN for AAG 
elevated colony-forming capacities, invasion, and ad-
hesion to laminin of the cancer cells. These results 
suggest that AAG, expressed in cancer cells inhibited 
proliferation, invasion, and metastasis of the cancer 
cells. 
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Introduction 
 
The α1-Acid glycoprotein (AAG) is a 44 kDa plasma 
protein. AAG is one of positive acute phase proteins and 
its concentration in plasma is known to increase approxi-
mately two to four fold following tissue injury (Kushner, 
1990; Stadnyk and Gauldie, 1991). It has been speculated 
that AAG plays an important role in inflammation and 
cancer, but its exact biological function is still unclear, 
despite extensive studies of AAG regarding its immuno-
regulatory role and binding to a number of diverse drugs 
(Ades et al., 1982; Alam and Papaconstantinou, 1992; 
Baumann et al., 1990; Hussain et al., 1995; Niewiarowski 
et al., 1975). The acute phase proteins are known to be 
synthesized mainly in the liver. The synthesis of the pro-
teins is regulated by IL-1, IL-6, TNF-α, IFN-γ, as well as 
by other stimulatory factors and cofactors. 
   In a recent study, we identified the expression of mRNA 
for AAG. The expression of the AAG mRNA in HT-29 
human colon carcinoma cells is regulated by cytokines 
(IL-1, IL-6, and TNF-α) in a manner that is characteristic 
of the acute phase response. The expression of AAG 
mRNA is up-regulated in well-differentiated HT-29 cells. 
The functional role of the AAG expressed in non-hepatic 
cancer cells has not yet been established. 
   In this paper, we report that the AAG may weaken the 
malignant potencies, the characteristics of proliferation, 
invasion, and metastasis of the HT-29 human colon carci-
noma cells using transfection experiments.  
 
 
Materials and Methods 
 
Cell and cell culture   HT-29 cells, derived from a colon ade-
nocarcinoma, were purchased from the American Type Culture 
Collection (USA), and maintained in RPMI 1640 that was sup-
plemented with 10% FBS. 
 
Molecules 
and 
Cells 
KSMCB 2001 
342 α1-Acid Glycoprotein in Cancer Cells Affects Malignancy 
 
 
Construction of the AAG expression vector  A construct of 
AAG was generated by a polymerase chain reaction amplifica-
tion of the full-length human AAG cDNA using oligonucleo-
tides 5′-ACGTGCCTCCTGGTCTCAGTAT-3′ (sense) and 5′-
TTAGCT GTTCCAAACACAGAAG-3′ (antisense). The ampli-
fied product of 764 bp was purified from an agarose gel and 
directionally cloned in a pCR3-unit expressing vector (Invitro-
gen, USA). E. coli (TOP10F’) were then transformed by the 
plasmid, selected colonies were harvested, the bacteria were 
lysed by alkali treatment, and the plasmid were purified for 
transfection in HT-29 cells. 
 
Transfection  The HT-29 cells were transfected in serum-free 
media using the calcium phosphate precipitation method (Gra-
ham and Vander, 1973) with the plasmid DNA inserted AAG 
full-length cDNA. Forty-eight hours after transfection, the cells 
were cultured in RPMI 1640 containing 10% FBS for 24 h. The 
cultured cells was diluted to ten-fold and inoculated to a culture 
flask with RPMI 1640 that was supplemented with 10% FBS 
and 1 mg/ml neomycin (Sigma, USA). The colonies that were 
resistant to neomycin were expanded, and the AAG protein ex-
pression was identified from conditioned mediums and cell ly-
sates using Western blot (Hong and Kang, 1998). 
 
Antisense oligodeoxynucleotide (ODN) to human AAG 
mRNA  A phosphorothioate analogue of antisense ODN to AAG 
mRNA, which was designed to bind the translation initiation 
codon (ATG), was synthesized by a DNA synthesizer (Millipore, 
USA). The sequence of antisense ODN was 5′-CAGG-
ACAGCGCCATACTGAG-3′, and the sequence of sense ODN 
(used as a control) was 5′-CTCAGTATGGCGCTGTCCTG-3′. 
Cancer cells were cultured with a serum-free medium contain-
ing DOTAP (Boehringer Mannheim, Germany) and 20 µM of 
sense or antisense ODN. Sixteen hours after culture, the total 
RNA was extracted from the cancer cells. A nested reverse tran-
scriptase-polymerase chain reaction (RT-PCR) was performed 
for identification of the AAG mRNA expression (Sense: 5′-
CCTTCTTTTACTTCACCCCCAAC-3′ Antisense: 5′-CATAG-
ACAGACAGCCCCCAGTTC-3′). 
 
Colony forming assay  The 104 cancer cells were resuspended 
in 1 ml of a serum-free medium containing 0.3% agar. The cells 
was then inoculated into a 33 mm plate coated with 0.6% agar. 
After 21 d, the number of colonies containing more than 100 
cells were counted. 
 
Invasion assay A 24-well transwell unit (12 µm pore size; Sig-
ma, USA) was used for the motility assay. The filters in the 
transwells were coated with 30 µg (0.6 mg/ml) of Matrigel per 
filter for 16 h at room temperature. Prior to the addition of the 
cells, an excess medium was removed from the upper compart-
ment. The lower compartment contained 0.5 µl of a serum-free 
medium that was supplemented with a platelet-derived growth 
factor (PDGF; 10 ng/ml) as a chemotactant. The 2 × 104 cells 
were resuspended in 100 µl of a serum-free medium, and placed 
in the upper compartment of the transwell unit for 5 h at 37°C in 
a humidified 95% air/5% CO2 atmosphere. The cells were fixed 
with methanol for 2 h and stained with the Wright method. The 
cells on the upper surface of the filter were removed by wiping 
with a cotton swab, and invasion was determined by counting 
the cells that migrated to the lower side of the filter with a phase 
contrast microscope at ×160 magnification. 
 
Adhesion assay   A 96-well culture plate was coated with 100 
µl of laminin (10 µg/ml) at 4°C overnight. The cells were then 
harvested and plated with 2 × 104 cells in 200 µl of serum-free 
medium. The wells were washed 3 h after incubation at 37oC 
and the numbers of adherent cells were estimated using spectro-
photometric absorbance following uptake of 3-[4,5] dimethyl-
thiazol-2-yl-2,5-Diphenyl-tetrazolium bromide (MTT). 
 
Statistical analysis  The statistical analyses were performed 
using the SAS program. The average, and the S.D of the tripli-
cate experiments, are shown. A p-value less than 0.05, based on 
the Student’s t-test, was considered to indicate statistical signifi-
cance. 
 
 
Results  
 
Overexpression of AAG in HT-29 cells  In order to iden-
tify insertion of AAG cDNA into the plasmid vector, the 
plasma vectors isolated from transformed E. coli, were 
digested with EcoR1 and HindIII, followed by agarose gel 
electrophoresis. As shown in Fig. 1A, one single band of 
764 bp was identified, indicating that the full length of 
cDNA of AAG was inserted into the plasmid vector. 
   To confirm the secretion of the AAG from the HT-29 
cancer cells, overexpressed by means of the transfection 
with the pCR3-AAG plasmid vector, a Western blot was 
performed on the concentrates of the culture medium. The 
result showed a AAG single band, indicating that the 
transfected HT-29 cancer cells secrete AAG. In order to 
verify the validity of the inhibitory effect of the antisense 
ODN on AAG synthesis, the concentrates of the medium 
from the HT-29 cells (16 h after treatment of the antisense 
ODN) were examined by Western blot. The antisense 
treatment decreased the expression of the AAG in the HT-
29 cells (Fig. 1B). 
   In order to determine the optional condition of infusion 
of antisense ODN, a nested RT-PCR was carried out from 
total RNA that was separated from the HT-29 cancer cells 
that were coincubated with 5-20 µM of antisense ODN, 
sense ODN, and DOTAP. The AAG mRNA expression 
was prominently suppressed when incubated with 10 µM 
antisense ODN and 13 µM DOTAP for 16 h (Fig. 2). 
 
Functional role of overexpressed AAG by transfection 
in HT-29 cancer cells  In order to examine the functional 
role of overexpressed AAG in HT-29 cancer cells, the 
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malignant characteristics (i.e. proliferation, invasion and 
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Fig. 1. A. Agarose gel electrophoretic pattern of EcoRI and 
HindIII-digested pCR3-unit, or pCR3-AAG plasmid vector. M, 
DNA molecular weight marker. B. Western blot analysis on the 
concentrate of the culture supernatant from HT-29 cells trans-
fected with the pCR3-AAG plasmid vector. When cultured cells 
were exponentially grown, sense or antisense ODN was treated 
at 37°C for 16 h. S, HT-29 cells exposed to sense ODN; AS, HT-
29 cells exposed to antisense ODNA; Ctr, control HT-29 cells 
transfected with pCR3-unit plasmid vector only; pCR3-AAG, 
HT-29 cells transfected with pCR3-AAG plasmid vector. 
 
 
 
 
 
 
 
 
Fig. 2. Nested RT-PCR analysis of the expression of AAG 
mRNA in HT-29 cells exposed to antisense or sense ODN. M, 
DNA molecular weight marker; WT, wild type HT-29 cells; S, 
HT-29 cells exposed to sense ODN; AS, HT-29 cells exposed to 
antisense ODN. 
 
 
metastasis of the HT-29 cancer cells) were investigated.  
    To determine the proliferation of the HT-29 cancer cells, 
the in vitro colony forming ability was examined. As 
shown in Fig. 3, the colony forming capability of the HT-
29 cancer cells that were transfected with the AAG-
expressed vector was markedly reduced, 267 ± 47, com-
pared with that of the control group, 470 ± 57 (P < 0.001). 
However, the colony-forming capability of the HT-29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Colony-forming capability of HT-29 cells transfected 
with the AAG-expression vector, exposed to 20 µM antisense or 
sense ODN for 16 h at 37°C. Mean ± S.D., * P < 0.001 vs Ctr;   
** P < 0.05 vs AS. WT, wild type HT-29 cells; Ctr, control HT-29 
cells transfected with pCR3-unit plasmid vector only; pCR3-
AAG, HT-29 cells transfected with pCR3-AAG plasmid vector; 
S, HT-29 cells exposed to sense ODN; AS, HT-29 cells exposed 
to antisense ODN.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Invasion of HT-29 cells transfected with the AAG-
expression vector, exposed to 20 µM antisense or sense ODN 
for 16 h at 37°C. Mean ± S.D., * P < 0.005 vs Ctr; ** P < 0.05 vs 
AS, WT, wild type HT-29 cells; Ctr, control HT-29 cells trans-
fected with pCR3-unit plasmid vector only; pCR3-AAG, HT-29 
cells transfected with pCR3-AAG plasmid vector; S, HT-29 
cells exposed to sense ODN; AS, HT-29 cells exposed to anti-
sense ODN. 
 
 
cancer cells that were exposed to 20 µM of sense for 16 h 
at 37°C significantly decreased, 362 ± 33, compared with 
the antisense ODN group, 533 ± 93 (P < 0.05). 
   As shown in Fig. 4, invasion (i.e. cell number per filter) 
of the HT-29 cancer cells that were transfected with the 
AAG-expressed vector prominently decreased, 117 ± 23 
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cells, compared with the control cells transfected with the 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Adhesion of HT-29 cells transfected with the AAG-
expression vector, exposed to 20 µM antisense, or sense ODN 
for 16 h at 37°C to laminin. Mean ± S.D. * P < 0.005 vs Ctr; ** P 
< 0.005 vs AS; † P < 0.05 vs WT; ‡ P < 0.005 vs WT; WT, wild 
type HT-29 cells; Ctr, control HT-29 cells transfected with the 
pCR3-unit plasmid vector only; pCR3-AAG, HT-29 cells trans-
fected with the pCR3-AAG plasmid vector; S, HT-29 cells ex-
posed to sense ODN; AS, HT-29 cells exposed to antisense 
ODN. 
 
 
pCR3-unit plasma vector, 231 ± 41 (P < 0.005). However, 
the cell numbers per filter of the HT-29 cancer cells that 
were exposed to 20 µM of sense for 16 h at 37°C signifi-
cantly decreased, 157 ± 41 cells, compared with the anti-
sense ODN group, 229 ± 34 cells (P < 0.05). 
   To determine the metastasis of the HT-29 cancer cells, 
the adhesion of the cancer cells to laminin was examined. 
As shown in Fig. 5, O.D. of the HT-29 cancer cells that 
were transfected with the AAG-expressed vector was pro-
foundly reduced, 0.081 ± 0.009, compared with that of 
control group, 0.126 ± 0.018 (P < 0.05). However, the 
O.D. of the HT-29 cancer cells that were exposed to 20 
µM of sense for 16 h at 37°C was significantly reduced, 
0.174 ± 0.016, compared with the antisense ODN group, 
0.221 ± 0.010 (P < 0.05). The O.D. of the sense, or anti-
sense ODN group, was elevated compared to the wild 
type cells, 0.128 ± 0.020 (P < 0.05, < 0.005, respectively). 
 
 
Discussion 
 
This present study demonstrates that the overexpression 
of the AAG in the HT-29 cancer cells weakens the malig-
nant potencies, but the reduced expression of the AAG in 
the HT-29 cancer cells by antisense ODN strengthens the 
malignant characteristics, proliferation, invasion, and me-
tastasis. Also, the overexpression of the AAG in the HT-
29 cancer cells increases the secretion of AAG, but the 
antisense treatment decreases the expression of the AAG. 
This study is thought to be the first to examine how the 
AAG of the human colon carcinoma cells regulates the 
malignant potencies. 
    In order to examine the metastasis of the HT-29 cancer 
cells in vitro, the adhesion of the cells to laminin, adhe-
sion assay, was carried out in this study. It has been well 
known that malignant cells have laminin receptors on the 
cell surface to bind laminin, one-component of the extra-
cellular matrix. In order to metastasize, the laminin recep-
tors of the cells for cancer cells first bind to laminin and 
are then intravasated (Gui et al., 1997; Lukacs et al., 
1993; Tuszynski et al., 1997; Ziober et al., 1996). Lukacs 
et al. (1993) reported that the gene encoding a highly im-
munogenic mycobacterial heat-shock protein (hsp65) was 
transfected into the murine macrophage tumor cell line 
J774, and the resulting hsp65-expressing cells (J774-
hsp65) were no longer able to produce tumors in syngene-
ic mice. The results clearly showed that transfection of 
the tumor cells with the bacterial hsp65 results in the in-
duction of immunity against the parent tumor cell line; 
this immunity was reflected in the generation of cytotoxic 
T cells, and protective immunity against the parent tumor. 
Currently, there is a great deal of interest in the use of 
gene transfer; for example, using IL-2- or TNF-encoding 
genes to increase the immunological recognition of cancer 
cells (Gutieerez et al., 1992; Miller, 1992). 
   When the HT-29 cells were cultured on polycarbonate 
coated chambers for 17 d in order to differentiate, or 
when exposed to a well-known differentiating agent (all-
trans retinoic acid), the AAG mRNAs were upregulated 
(Lee et al., 2001).  
   This result provides evidence that the upregulation of 
the AAG mRNAs weaken the malignant potency by an 
unknown intracellular mechanism without the action of 
the secreted AAG. The significantly elevated adhesiveness 
of the tumor cells (following sense or antisense ODN 
treatment), when compared to the wild type cells in the 
present study, remains to be elucidated.   
   A plausible explanation for the role of AAG could be 
that the AAG may weaken the malignant potencies of the 
HT-29 human colon carcinoma cells, the characteristics of 
proliferation, invasion, and metastasis. Further studies on 
the roles of the other acute phase proteins in cancer cells 
are under investigation in our laboratory. 
 
Acknowledgments  This work was supported by the Korea 
Science and Engineering Foundation (KOSEF), grant 93-0800-
05-01-3. 
 
 
References 
 
Ades, E. W., Hinson, A., Chapuis-Cellier, C., and Arnaud, P. 
(1982) Modulation of the immune response by plasma prote-
ase inhibitors. I. Alpha2-macroglobulin and alpha1-antitryp-
sin inhibit natural killing and antibody-dependent cell medi-
 Soo Young Lee et al. 345 
 
 
ated cytotoxicity. Scand. J. Immunol. 5, 109−113. 
Alam, T. and Papaconstantinou, J. (1992) Interaction of acute-
phase-inducible and liver-enriched nuclear factors with the 
promoter region of the mouse α1-acid glycoprotein gene-1. 
Biochemistry 31, 1928−1936. 
Baumann, H., Jahreis, G. P., and Morella, K. K. (1990) Interac-
tion of cytokine- and glucocorticoid-response elements of 
acute-phase plasma protein genes. J. Biol. Chem. 265, 
22275−22281. 
Graham, F. L. and Vander, E. B. (1973) A new technique for the 
assay of infectivity of human 5 DNA. Virology 52, 456−463. 
Gui, G. P., Puddefoot, J. R., Vinson, G. P., Wells, C. A., and Car-
penter, R. (1997) Altered cell-matrix contact: a prerequisite 
for breast cancer metastasis. Br. J. Cancer 75, 623−633. 
Gutieerez, A. A., Lemoine, N. R., and Sikora, K. (1992) Gene 
therapy for cancer. Lancet 339, 715. 
Hong, S. J. and Kang, H. S. (1998) Expression and secretion of 
foreign proteins in yeast using the ADH1 promoter and 97 K 
killer toxin signal sequence. J. Biochem. Mol. Biol. 31, 123− 
129. 
Hussain, R., Lucas, S. B., Kifayet, A., Jamil, S., Raynes, J., 
Uqaili, Z., Dockrell, H. M., Chiang, T. H., and McAdam, K. 
P. W. J. (1995) Clinical and histological discrepancies in di- 
agnosis of ENL reactions classified by assessment of acute 
phase proteins SAA and CRP. Int. J. Lepro. 63, 222−230. 
Kushner, I. (1990) C-reactive proteins and the acute phase re- 
sponse. Hospital Practice 25, 13−28. 
Lee, S. Y., Lim, J. W., Kim, Y. M., Lee, I. H., Choi, Y. C., and 
Park, K. C. (2001) Induction of α1-acid glycoprotein mRNA 
by cytokines and differentiation in human colon carcinoma 
cell. Mol. Cells 11, 164−169. 
Lukacs, K. V., Lowrie, D. B., Stokes, R. W., and Colston, M. J. 
(1993) Tumor cells transfected with a bacterial heat-shock 
gene lose tumorigenicity and induce protection against tu-
mors. J. Exp. Med. 178, 343−348. 
Miller, A. D. (1992) Human gene therapy comes of age. Nature 
357, 455. 
Niewiarowski, S., Lukasiewicz, H., Nath, N., and Tai Sha, A. 
(1975) Inhibition of human platelet aggregation by dipyri-
damole and two related compounds and its modification by 
α1-acid glycoproteins of human plasma. J. Lab. Clin. Med. 
86, 64−76. 
Stadnyk, A. W. and Gauldie, J. (1991) The acute phase protein 
response during parasitic infection. Immunol. Today 12, A7− 
A12. 
Tuszynski, G. P., Wang, T. N., and Berger, D. (1997) Adhesive 
proteins and the hematogenous spread of cancer. Acta 
Haematol. 97, 29−39. 
Ziober, B. L., Lin, C. S., and Kramer, R. H. (1996) Laminin-
binding integrins in tumor progression and metastasis. Semin. 
Cancer Biol. 7, 119−128.  
 
